Two Sigma Investments, LP Uro Gen Pharma Ltd. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Two Sigma Investments, LP holds 87,034 shares of URGN stock, worth $915,597. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,034

Previous 100,422 13.33%

Holding current value

$915,597

Previous $1.69 Million 34.42%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.7 - $17.92 $170,027 - $239,912	-13,388 Reduced 13.33%	87,034 $1.11 Million
Q2 2024 Aug 14, 2024	BUY	$12.72 - $19.2 $253,446 - $382,560	19,925 Added 24.75%	100,422 $1.69 Million
Q1 2024 May 15, 2024	SELL	$13.81 - $19.33 $694,062 - $971,487	-50,258 Reduced 38.44%	80,497 $1.21 Million
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $114,580 - $167,918	10,541 Added 8.77%	130,755 $1.96 Million
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $887,527 - $2.27 Million	100,399 Added 506.68%	120,214 $1.68 Million
Q2 2023 Aug 14, 2023	BUY	$8.75 - $14.29 $173,381 - $283,156	19,815 New	19,815 $205,000
Q2 2021 Aug 16, 2021	SELL	$15.2 - $20.94 $300,960 - $414,612	-19,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$17.99 - $26.96 $356,201 - $533,808	19,800 New	19,800 $386,000
Q4 2018 Feb 14, 2019	SELL	$38.35 - $50.39 $228,335 - $300,022	-5,954 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $247,984 - $307,821	5,954 New	5,954 $281,000
Q2 2018 Aug 14, 2018	BUY	$48.35 - $65.33 $724,089 - $978,382	14,976 New	14,976 $745,000
Q1 2018 May 15, 2018	SELL	$38.64 - $57.54 $287,327 - $427,867	-7,436 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$27.28 - $43.26 $202,854 - $321,681	7,436	7,436 $277,000

Others Institutions Holding URGN

# of Institutions

130

Shares Held

35.9M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $239M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Uro Gen Pharma Ltd. Transaction History